Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? the West Birmingham Malignant Hypertension Project

Hypertension Research

Volumn 36, Issue 6, 2013, Pages 546-549

  Shantsila, Alena ^a   Lane, Deirdre A ^a   Beevers, D Gareth ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

body mass index; malignant hypertension; obesity; outcomes

Indexed keywords

CREATININE;

ADULT; ADVERSE OUTCOME; ARTICLE; BODY MASS; DEATH; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; OBESITY; PROTEINURIA; RENAL REPLACEMENT THERAPY; RETINOPATHY; SMOKING; TARGET ORGAN; UNDERWEIGHT;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; CREATININE; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GREAT BRITAIN; HUMANS; HYPERTENSION, MALIGNANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RENAL DIALYSIS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84878903109     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.222     Document Type: Article

References (10)

1. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336-345.
2. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-e526.
3. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13: 915-924.
4. Stamler R, Ford CE, Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the hypertension detection and follow-up program. Hypertension 1991; 17: 553-564.
5. Phillips A, Shaper AG. Relative weight and major ischaemic heart disease events in hypertensive men. Lancet 1989; 1: 1005-1008. (Pubitemid 19123584)
6. Kannel WB, Zhang T, Garrison RJ. Is obesity-related hypertension less of a cardio vascular risk? The Framingham Study. Am Heart J 1990; 120: 1195-1201. (Pubitemid 20377295)
7. Leishman AW. Hypertension: treated and untreated; a study of 400 cases. Br Med J 1959; 1: 1361-1368.
8. Lip GY, Beevers M, Beevers DG. Does renal function improve after diagnosis of malignant phase hypertension? J Hypertens 1997; 15: 1309-1315. (Pubitemid 27453184)
9. van den Born BJ, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens 2007; 20: 900-906. (Pubitemid 47176352)
10. Shantsila A, Shantsila E, Lip GY. Malignant hypertension: a rare problem or is it underdiagnosed? Curr Vasc Pharmacol 2010; 8: 775-779.